Cytokeratin-19 Fragments in Serum (CYFRA 21-1) as a Marker in Primary Liver Cancer

British Journal of Cancer - United Kingdom
doi 10.1038/sj.bjc.6601026
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Decreased Levels of Serum Cytokeratin 19 Fragment CYFRA 21-1 Predict Objective Response to Chemotherapy in Patients With Non-Small Cell Lung Cancer

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2013English

Clinical Impact of CYFRA 21 – 1 as a Tumor Marker for Regional and Distant Tumor Control in Advanced Oropharyngeal Cancer

2018English

Correction: Quantification of CYFRA 21-1 and a CYFRA 21-1–anti-Cyfra 21-1 Autoantibody Immune Complex for Detection of Early Stage Lung Cancer

Chemical Communications
SurfacesAlloysMaterials ChemistryCoatingsMetalsOpticalMagnetic MaterialsFilmsCatalysisChemistryElectronicCompositesCeramics
2019English

Preoperative CYFRA 21-1 Level as a Prognostic Indicator in Resected Nonsmall Cell Lung Cancer

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
1998English

Identification of Keratin 19-Positive Cancer Stem Cells Associating Human Hepatocellular Carcinoma Using CYFRA 21-1

Cancer Medicine
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2017English

Fine-Needle Aspirates CYFRA 21-1 Is a Useful Tumor Marker for Detecting Axillary Lymph Node Metastasis in Breast Cancer Patients

PLoS ONE
Multidisciplinary
2013English

CYFRA 21‐1 and CEA Combination Assay in EMPD

British Journal of Dermatology
DermatologyMedicine
2019English

The Role of Serum Cytokeratin 19 Fragment in Transarterial Infusion Against Invasive Bladder Cancer

Open Journal of Urology
2013English

S100β as a Serum Marker in Endocrine Resistant Breast Cancer

BMC Medicine
Medicine
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy